Cargando…
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
The CRISPR/Cas9 system facilitates precise DNA modifications by generating RNA-guided blunt-ended double-strand breaks. We demonstrate that guide RNA pairs generate deletions that are repaired with a high level of precision by non-homologous end-joining in mammalian cells. We present a method called...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856974/ https://www.ncbi.nlm.nih.gov/pubmed/26762978 http://dx.doi.org/10.1093/nar/gkv1542 |
_version_ | 1782430575020212224 |
---|---|
author | Geisinger, Jonathan M. Turan, Sören Hernandez, Sophia Spector, Laura P. Calos, Michele P. |
author_facet | Geisinger, Jonathan M. Turan, Sören Hernandez, Sophia Spector, Laura P. Calos, Michele P. |
author_sort | Geisinger, Jonathan M. |
collection | PubMed |
description | The CRISPR/Cas9 system facilitates precise DNA modifications by generating RNA-guided blunt-ended double-strand breaks. We demonstrate that guide RNA pairs generate deletions that are repaired with a high level of precision by non-homologous end-joining in mammalian cells. We present a method called knock-in blunt ligation for exploiting these breaks to insert exogenous PCR-generated sequences in a homology-independent manner without loss of additional nucleotides. This method is useful for making precise additions to the genome such as insertions of marker gene cassettes or functional elements, without the need for homology arms. We successfully utilized this method in human and mouse cells to insert fluorescent protein cassettes into various loci, with efficiencies up to 36% in HEK293 cells without selection. We also created versions of Cas9 fused to the FKBP12-L106P destabilization domain in an effort to improve Cas9 performance. Our in vivo blunt-end cloning method and destabilization-domain-fused Cas9 variant increase the repertoire of precision genome engineering approaches. |
format | Online Article Text |
id | pubmed-4856974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48569742016-05-09 In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining Geisinger, Jonathan M. Turan, Sören Hernandez, Sophia Spector, Laura P. Calos, Michele P. Nucleic Acids Res Methods Online The CRISPR/Cas9 system facilitates precise DNA modifications by generating RNA-guided blunt-ended double-strand breaks. We demonstrate that guide RNA pairs generate deletions that are repaired with a high level of precision by non-homologous end-joining in mammalian cells. We present a method called knock-in blunt ligation for exploiting these breaks to insert exogenous PCR-generated sequences in a homology-independent manner without loss of additional nucleotides. This method is useful for making precise additions to the genome such as insertions of marker gene cassettes or functional elements, without the need for homology arms. We successfully utilized this method in human and mouse cells to insert fluorescent protein cassettes into various loci, with efficiencies up to 36% in HEK293 cells without selection. We also created versions of Cas9 fused to the FKBP12-L106P destabilization domain in an effort to improve Cas9 performance. Our in vivo blunt-end cloning method and destabilization-domain-fused Cas9 variant increase the repertoire of precision genome engineering approaches. Oxford University Press 2016-05-05 2016-01-13 /pmc/articles/PMC4856974/ /pubmed/26762978 http://dx.doi.org/10.1093/nar/gkv1542 Text en © The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Methods Online Geisinger, Jonathan M. Turan, Sören Hernandez, Sophia Spector, Laura P. Calos, Michele P. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title | In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title_full | In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title_fullStr | In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title_full_unstemmed | In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title_short | In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining |
title_sort | in vivo blunt-end cloning through crispr/cas9-facilitated non-homologous end-joining |
topic | Methods Online |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856974/ https://www.ncbi.nlm.nih.gov/pubmed/26762978 http://dx.doi.org/10.1093/nar/gkv1542 |
work_keys_str_mv | AT geisingerjonathanm invivobluntendcloningthroughcrisprcas9facilitatednonhomologousendjoining AT turansoren invivobluntendcloningthroughcrisprcas9facilitatednonhomologousendjoining AT hernandezsophia invivobluntendcloningthroughcrisprcas9facilitatednonhomologousendjoining AT spectorlaurap invivobluntendcloningthroughcrisprcas9facilitatednonhomologousendjoining AT calosmichelep invivobluntendcloningthroughcrisprcas9facilitatednonhomologousendjoining |